Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography

被引:60
作者
Frye, RF [1 ]
Stiff, DD [1 ]
机构
[1] UNIV PITTSBURGH,MED CTR,CTR CLIN PHARMACOL,PITTSBURGH,PA 15261
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 686卷 / 02期
关键词
chlorzoxazone; 6-hydroxychlorzoxazone;
D O I
10.1016/S0378-4347(96)00227-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and reproducible method is described for the determination of the cytochrome P450 enzyme 2E1 substrate chlorzoxazone and its primary metabolite 6-hydroxychlorzoxazone in human plasma and urine. Plasma or diluted urine were acidified, incubated with beta-glucuronidase and then were extracted with diethyl ether. Separation of the analytes was achieved on a C-18 column with UV detection set at 283 nm. Excellent linearity was observed over the concentration ranges of 100-3000 ng/ml and 4-400 mu g/ml in plasma and urine, respectively. The intra-assay variability was less than or equal to 5.1% and the inter-assay variability was less than or equal to 8.2% for each compound in each matrix. The method presented is applicable to pharmacokinetic and pharmacogenetic studies utilizing chlorzoxazone.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 13 条
[1]   PHARMACOKINETICS OF CHLORZOXAZONE IN HUMANS [J].
DESIRAJU, RK ;
RENZI, NL ;
NAYAK, RK ;
NG, KT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (09) :991-994
[2]   VARIABILITY IN THE DISPOSITION OF CHLORZOXAZONE [J].
DEVRIES, JD ;
SALPHATI, L ;
HORIE, S ;
BECKER, CE ;
HOENER, BA .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (07) :587-597
[3]   URINARY-EXCRETION OF 6-HYDROXYCHLORZOXAZONE AS AN INDEX OF CYP2E1 ACTIVITY [J].
DREISBACH, AW ;
FERENCZ, N ;
HOPKINS, NE ;
FUENTES, MG ;
REGE, AB ;
GEORGE, WJ ;
LERTORA, JJL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (05) :498-505
[4]  
Frye Reginald F., 1993, Pharmaceutical Research (New York), V10, pS388
[5]   ASSESSMENT OF CYTOCHROME P4502E1 INDUCTION IN ALCOHOLIC PATIENTS BY CHLORZOXAZONE PHARMACOKINETICS [J].
GIRRE, C ;
LUCAS, D ;
HISPARD, E ;
MENEZ, C ;
DALLY, S ;
MENEZ, JF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1503-1508
[6]   SINGLE-DOSE DISULFIRAM INHIBITION OF CHLORZOXAZONE METABOLISM - A CLINICAL PROBE FOR P450-2E1 [J].
KHARASCH, ED ;
THUMMEL, KE ;
MHYRE, J ;
LILLIBRIDGE, JH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :643-650
[7]  
KIM RB, 1994, PHARMACOGENETICS, V4, P162
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CHLORZOXAZONE AND 6-HYDROXYCHLORZOXAZONE IN SERUM - A TOOL FOR INDIRECT EVALUATION OF CYTOCHROME P4502E1 ACTIVITY IN HUMANS [J].
LUCAS, D ;
BERTHOU, F ;
GIRRE, C ;
POITRENAUD, F ;
MENEZ, JF .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 622 (01) :79-86
[9]   HYDROXYLATION OF CHLORZOXAZONE AS A SPECIFIC PROBE FOR HUMAN LIVER CYTOCHROME-P-450IIE1 [J].
PETER, R ;
BOCKER, R ;
BEAUNE, PH ;
IWASAKI, M ;
GUENGERICH, FP ;
YANG, CS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (06) :566-573
[10]  
Settel E, 1959, CLIN MED, V6, P1373